Mercer Global Advisors Inc Ginkgo Bioworks Holdings, Inc. Transaction History
Mercer Global Advisors Inc
- $39.5 Billion
- Q2 2024
A detailed history of Mercer Global Advisors Inc transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 55,010 shares of DNA stock, worth $460,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,010
Previous 166,852
67.03%
Holding current value
$460,983
Previous $194,000
90.72%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DNA
# of Institutions
220Shares Held
718MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$585 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$263 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...